Cantor Fitzgerald & Culper Research
2 shared events · Importance 3 · Last updated Jul 21, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Cantor Fitzgerald: Cantor Fitzgerald downgraded ADMA Biologics' stock, citing disappointment with the company's response to the Culper Research report, further contributing to the stock's decline.
Culper Research: Culper Research is the investigative firm that published a report alleging ADMA Biologics engaged in channel stuffing and had misleading revenue growth, triggering the stock drop and subsequent lawsuits.
Apr 01, 2026 · 301 articles
Regulatory
Cantor Fitzgerald: Cantor Fitzgerald downgraded ADMA Biologics stock from Overweight to Neutral following the Culper Research report.
Culper Research: Culper Research published a report alleging channel stuffing and undisclosed related party transactions at ADMA, triggering the stock decline and subsequent lawsuits.
Jun 14, 2026 · 294 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Cantor Fitzgerald and Culper Research interact across events, view sentiment trends, and discover connected entities.
Open Dashboard